Compare pharmacokinetic profiles across peptides, GLP-1 agonists, testosterone esters, and more. Half-life determines dosing frequency, time to steady state, and how your levels fluctuate between doses.
In pharmacokinetics, half-life is the time it takes for the concentration of a compound in your blood to decrease by exactly 50%. It is one of the most important parameters governing how a compound behaves in your body.
Half-life directly determines dosing frequency. Compounds with short half-lives (like BPC-157 at 30 minutes) are typically dosed daily because they clear quickly. Compounds with long half-lives (like semaglutide at 6.7 days) can be dosed once a week because they remain active for extended periods.
Steady state is reached after approximately 5 half-lives of consistent dosing. At this point, the amount of compound entering your system equals the amount being cleared with each dose cycle. This is when blood levels stabilize into a predictable pattern and the compound reaches its full pharmacokinetic potential.
The range of half-lives across commonly used compounds is enormous — from 15 minutes (glutathione) to 53 days (testosterone undecanoate). This 5,000x range is why dosing frequency varies so dramatically between compounds and why tracking levels matters.
Time to reach steady state (5 × half-life) and typical dosing frequency for each compound.
Common questions about compound half-lives and pharmacokinetics.